Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANRS 167 Lamidol
NCT02527096Phase 2Completed
- Sponsor
- ANRS
- Start
- Sep 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dolutegravir, lamivudine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Started Sep 2015; status: completed.
02
Drugs
dolutegravirlamivudine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02527096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02527096.